Design, synthesis and pharmacological evaluation of novel polycyclic heteroarene ethers as PDE10A inhibitors: Part I

We report analogue-based rational design and synthesis of two novel series of polycyclic heteroarenes, pyrrolo[3,2-b]quinolines and pyrido[2,3-b]indoles, tethered to a biaryl system by a methyl-, ethyl- or propyl ether as PDE10A inhibitors. A number of analogues were prepared with variable chain len...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters 2014-05, Vol.24 (9), p.2073-2078
Main Authors: Das, Sanjib, Harde, Rajendra L., Shelke, Dnyaneshwar E., Khairatkar-Joshi, Neelima, Bajpai, Malini, Sapalya, Ratika S., Surve, Harshada V., Gudi, Girish S., Pattem, Rambabu, Behera, Dayanidhi B., Jadhav, Satyawan B., Thomas, Abraham
Format: Article
Language:English
Subjects:
Animals
Drug Design
Humans
Indoles - chemical synthesis
Indoles - chemistry
Indoles - metabolism
Indoles - pharmacology
Met-ID studies
Microsomes, Liver - metabolism
PDE10A inhibitors
Phosphodiesterase Inhibitors - chemical synthesis
Phosphodiesterase Inhibitors - chemistry
Phosphodiesterase Inhibitors - metabolism
Phosphodiesterase Inhibitors - pharmacology
Phosphoric Diester Hydrolases - metabolism
Pyrido[2,3-b]indoles
Pyrrolo[3,2-b]quinolines
Quinolines - chemical synthesis
Quinolines - chemistry
Quinolines - metabolism
Quinolines - pharmacology
Rats
Structure-Activity Relationship
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We report analogue-based rational design and synthesis of two novel series of polycyclic heteroarenes, pyrrolo[3,2-b]quinolines and pyrido[2,3-b]indoles, tethered to a biaryl system by a methyl-, ethyl- or propyl ether as PDE10A inhibitors. A number of analogues were prepared with variable chain length and evaluated for their ability to block PDE10A enzyme using a radiometric assay. Detailed SAR analyses revealed that compounds with an ethyl ether linker are superior in potency compared to compounds with methyl or propyl ether linkers. These compounds, in general, showed poor metabolic stability in rat and human liver microsomes. The metabolic profile of one of the potent compounds was studied in detail to identify metabolic liabilities of these compounds. Structural modifications were carried out that resulted in improved metabolic stability without significant loss of potency.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2014.03.054